Radioembolization for the treatment of liver tumors general principles.
about
Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesYttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies.Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)Current management of hepatocellular carcinoma.Radioembolization of hepatic tumorsRETRACTED ARTICLE: A Case Series of Four Patients With Clinically Significant Radiomicrosphere Pneumonitis After Yttrium-90 Radioembolization from the Perspective of Lung Dosimetry.Quantitative liver tumor blood volume measurements by a C-arm CT post-processing software before and after hepatic arterial embolization therapy: comparison with MDCT perfusion.Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma.Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system.PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment EfficacyCeliac artery stenting to facilitate hepatic yttrium-90 radioembolization therapy.Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumorsPET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor ResponseTreating hepatocellular carcinoma with 90Y-bearing microspheres: a reviewLatest selective internal radiation therapy recommendations from EU proctors.Radioembolization dosimetry: the road ahead.Other non-surgical treatments for liver cancer.Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors.Hepatic arterial configuration in relation to the segmental anatomy of the liver; observations on MDCT and DSA relevant to radioembolization treatment.Effect of yttrium-90 radioembolization on outcomes in Asian patients with early to advanced stage hepatocellular carcinoma.Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinoma.Trial Watch: Anticancer radioimmunotherapy.Glioblastoma microvesicles promote endothelial cell proliferation through Akt/beta-catenin pathway.Posttreatment PET-CT-confirmed intrahepatic radioembolization performed without coil embolization, by using the antireflux Surefire Infusion System.Yttrium-90 resin microsphere radioembolization using an antireflux catheter: an alternative to traditional coil embolization for nontarget protection.Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases.Predictive SIRT dosimetry based on a territorial model.Internal dosimetry for radioembolization therapy with Yttrium-90 microspheres.The effect of selective internal radiation therapy with yttrium-90 resin microspheres on lung carbon monoxide diffusion capacity.Radioembolization for hepatocellular carcinoma: gaining insight on a personalized approach.Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies.A Supramolecular Approach for Liver Radioembolization.Radiation Therapy for Hepatocellular Carcinoma
P2860
Q27023616-8071279E-5990-41B8-86B2-1B01C9D54CD2Q30353464-9EBDC069-84E8-4FA9-934A-92A2EE8EEA18Q30657649-1AADB398-1559-4197-8515-80060D7D9281Q33582165-576B2E6A-8164-4EBB-9CA1-529704452591Q33820777-DEC0CC01-1BF0-4A35-84AF-F28E3378AB87Q35162702-67ED1A89-0A09-4ED6-AB2D-9053CD805446Q35721266-8BCDC731-CDB7-4F12-9589-23D741EA0304Q36062588-E9635C38-1694-48F3-B3E2-655935DD81CAQ36083302-27B5655A-2082-4941-9C81-D945F476E20FQ36194191-CB4F2613-5900-4C6B-84DE-699B73419D6DQ36470428-DBEBE6F9-FD11-49A3-B32A-B1BE49DB9445Q36865115-D160410B-98F7-4F4B-907F-39E85BD93873Q36874720-3EF2A2F6-7422-4B26-8AF8-C3F69062216DQ37474833-3C16E2E9-3DBB-411A-887E-FB8A4AB1645AQ38283677-47F89BB2-E8D1-4555-8B65-C904434362C9Q38299367-12812E06-0CF8-4BFB-997E-8EF5DE311A01Q38685463-F7E94213-06C2-4BD3-B2B2-AB4B26062FEFQ38739690-433468D6-8D33-4AE1-916F-1BF79A214518Q39004808-EDD89BDA-637A-4310-A071-7DEE56F8C4D7Q40175899-BDB76A02-4828-47C3-B6CB-67CEBFA4568DQ40641966-9955186D-711B-4E1E-BDEA-61C112536D3EQ40705749-4EC24416-794A-429D-9D5C-63804802DAD5Q42847992-024E433B-24ED-4C3D-B936-D05CB9F2A94DQ42856814-B7AAB1F9-94A4-4573-8AC4-DD414043A3E5Q45205037-72CBB481-FFA1-4F37-A780-83FF5758241BQ46346929-665ECF3A-8AE3-4E84-A0BB-6F77524C45DEQ46657713-AB1F81A5-E383-4D3F-8064-554417B73141Q47171915-6AB087C9-A7C4-4F81-9DF7-D19851EF236CQ47826137-757B81E2-09E3-4A35-987D-3158EF33A7E0Q48334258-29AA15E3-361B-4CE1-868B-706FEEBE461DQ50220738-9B352B88-505A-4637-90C5-7C88F8957797Q51743178-EA3F7F63-9057-4324-8D93-F3219673B1CFQ55128492-CAE1994B-9129-425A-AE9A-66A494190328Q57433607-A0D13713-948B-4D16-BBC6-E164B5F4C753
P2860
Radioembolization for the treatment of liver tumors general principles.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Radioembolization for the treatment of liver tumors general principles.
@en
Radioembolization for the treatment of liver tumors general principles.
@nl
type
label
Radioembolization for the treatment of liver tumors general principles.
@en
Radioembolization for the treatment of liver tumors general principles.
@nl
prefLabel
Radioembolization for the treatment of liver tumors general principles.
@en
Radioembolization for the treatment of liver tumors general principles.
@nl
P2093
P1476
Radioembolization for the treatment of liver tumors general principles
@en
P2093
Andrew Kennedy
Douglas Coldwell
Harpreet Wasan
P356
10.1097/COC.0B013E3181F47583
P577
2012-02-01T00:00:00Z